Panic surrounding dengue or chikungunya and many new testing centres having come up in the state capital - diaognosing more ...

Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should spark some buyer’s delight. | Sanofi has released phase 3 data from the LUNA 3 trial of rilzabrutinib that should ...

in HCV-positive cirrhotic patients with substantial thrombocytopenia. At week 4, platelet counts of ≥100,000 cells/mm 3 were achieved by 95% of evaluable patients (21 of 22) in the 75-mg group ...

At this time, I would like to welcome everyone to Karyopharm Therapeutics third quarter 2024 financial results conference ...

Research from the Wellcome Sanger Institute reveals that younger stem cell donors lead to better transplant outcomes.

Rajasthan High Court rejected a petition by the father of a minor rape victim for termination of his daughter's 26-weeks ...

Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.

Background Immune disorders are key heart failure (HF) triggers, but little is known about whether the status of immunity ...

Background: The HELLP syndrome is a serious complication in pregnancy characterized by haemolysis, elevated liver enzymes and low platelet count occurring ... 70 U/L), and platelets < 100·10 ...

But in the summer before his freshman year at North Branford High, Nicolas’ blood platelets dropped significantly ... Nicolas’ platelet count increased and returned to normal in July, Anthony said. He ...